These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9490665)

  • 1. Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies.
    Yokoyama A; Okabe-Kado J; Wakimoto N; Kobayashi H; Sakashita A; Maseki N; Nakamaki T; Hino Ki; Tomoyasu S; Tsuruoka N; Motoyoshi K; Nagata N; Honma Y
    Blood; 1998 Mar; 91(6):1845-51. PubMed ID: 9490665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia.
    Okabe-Kado J; Kasukabe T; Honma Y
    Leuk Lymphoma; 1998 Dec; 32(1-2):19-28. PubMed ID: 10036998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia.
    Yokoyama A; Okabe-Kado J; Sakashita A; Maseki N; Kaneko Y; Hino K; Tomoyasu S; Tsuruoka N; Kasukabe T; Honma Y
    Blood; 1996 Nov; 88(9):3555-61. PubMed ID: 8896423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia.
    Niitsu N; Okabe-Kado J; Nakayama M; Wakimoto N; Sakashita A; Maseki N; Motoyoshi K; Umeda M; Honma Y
    Blood; 2000 Aug; 96(3):1080-6. PubMed ID: 10910925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia.
    Wakimoto N; Yokoyama A; Okabe-Kado J; Nagata N; Motoyoshi K; Honma Y
    Br J Cancer; 1998 Jun; 77(12):2298-303. PubMed ID: 9649149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of differentiation inhibitory factor nm23 mRNA in monoblastic crisis of a patient with chronic myelogenous leukemia.
    Wakimoto N; Yokoyama A; Mukai Y; Kuwada N; Yamashita T; Matsumura T; Nakamura Y; Kanatani Y; Nagata N; Okabe-Kado J; Honma Y; Motoyoshi K
    Int J Hematol; 1998 Apr; 67(3):313-8. PubMed ID: 9650453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum nm23-H1 protein as a prognostic factor in hematological malignancies.
    Okabe-Kado J
    Leuk Lymphoma; 2002 Apr; 43(4):859-67. PubMed ID: 12153176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of nm23 genes in acute myeloid leukemia and its clinical significance].
    Meng QX; Jiang R; Yang BQ; Zhang HY; Liu J; Pang LP; Wang J
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):369-71. PubMed ID: 12941193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia.
    List AF; Spier CS; Grogan TM; Johnson C; Roe DJ; Greer JP; Wolff SN; Broxterman HJ; Scheffer GL; Scheper RJ; Dalton WS
    Blood; 1996 Mar; 87(6):2464-9. PubMed ID: 8630412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family.
    Martinez R; Venturelli D; Perrotti D; Veronese ML; Kastury K; Druck T; Huebner K; Calabretta B
    Cancer Res; 1997 Mar; 57(6):1180-7. PubMed ID: 9067290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia.
    Shimamoto T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Fujimura T; Iwama H; Nakazawa S; Toyama K
    Blood; 1995 Oct; 86(8):3173-80. PubMed ID: 7579412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.
    Iizuka N; Oka M; Noma T; Nakazawa A; Hirose K; Suzuki T
    Cancer Res; 1995 Feb; 55(3):652-7. PubMed ID: 7530600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma.
    Niitsu N; Okabe-Kado J; Kasukabe T; Yamamoto-Yamaguchi Y; Umeda M; Honma Y
    Blood; 1999 Nov; 94(10):3541-50. PubMed ID: 10552965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma level of differentiation inhibitory factor nm23-H1 protein correlates with risk factors for myelodysplastic syndrome.
    Ito Y; Okabe-Kado J; Honma Y; Iwase O; Shimamoto T; Ohyashiki JH; Ohyashiki K
    Leukemia; 2002 Feb; 16(2):165-9. PubMed ID: 11840281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical evaluation of nm23-H1 gene product in transitional cell carcinoma of the bladder.
    Nakopoulou LL; Constandinides CA; Tzonou A; Lazaris AC; Zervas A; Dimopoulos CA
    Histopathology; 1996 May; 28(5):429-35. PubMed ID: 8735718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of NM23-H(1) mRNA in acute leukemia].
    Wu S; Zhao C
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):367-9. PubMed ID: 12137595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of nm23 protein expression in renal cell carcinomas.
    Nakagawa Y; Tsumatani K; Kurumatani N; Cho M; Kitahori Y; Konishi N; Ozono S; Okajima E; Hirao Y; Hiasa Y
    Oncology; 1998; 55(4):370-6. PubMed ID: 9663430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. nm23-H1 expression in nasopharyngeal carcinoma: correlation with clinical outcome.
    Guo X; Min HQ; Zeng MS; Qian CN; Huang XM; Shao JY; Hou JH
    Int J Cancer; 1998 Dec; 79(6):596-600. PubMed ID: 9842967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.